TY - JOUR
AU - Smith, Michael, J.
AB - Abstract Therapy for endocarditis due to Pseudomonas aeruginosa is complicated by the emergence of resistance during therapy, lack of universally available synergistic antimicrobial agents, and unacceptably high morbidity and mortality rates. The authors report a case of aortic valve endocarditis due to P. aeruginosa in which resistance to piperacillin developed during combined therapy with tobramycin. Bacteriologic cure was obtained with a combination of imipenem/cilastatin and tobramycin. The authors review six other cases of P. aeruginosa endovascular infections treated with imipenem. This content is only available as a PDF. Author notes * Infectious Diseases Section, Washington University, St. Louis, Missouri. © 1992 by The University of Chicago
TI - Treatment of Endocarditis Due to Pseudomonas aeruginosa with Imipenem
JF - Clinical Infectious Diseases
DO - 10.1093/clinids/14.1.353
DA - 1992-01-01
UR - https://www.deepdyve.com/lp/oxford-university-press/treatment-of-endocarditis-due-to-pseudomonas-aeruginosa-with-imipenem-nYaYOR7F0T
SP - 353
EP - 354
VL - 14
IS - 1
DP - DeepDyve
ER -